![Jennifer Minai-Azary](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 228 029 $ in data 31/05/2026
Jennifer Minai-Azary is currently Director at KAHR Medical Ltd. since 2022.
Jennifer is Treasurer at Millendo Therapeutics US, Inc. and Chief Financial Officer & Treasurer at Context Therapeutics, Inc. since 2021.
Former roles include Director-Technical Accounting at PAREXEL International Corp.
and Vice President-Finance at Millendo Therapeutics, Inc. from 2013 to 2021.
Education includes undergraduate and graduate degrees from the University of Michigan.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/04/2026 | 80.010 ( 0,09% ) | 228 029 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Direttore Finanziario/CFO | 01/11/2021 |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Direttore/Membro del Consiglio | 11/07/2022 |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Treasurer | - |
| Società | Posizione | Fine |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
